Publication | Closed Access
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial
101
Citations
28
References
2022
Year
Treatment And PreventionHuman RetrovirusImmunologyAntiviral ResponseIl-15 Superagonist N-803Antiviral TherapyAutoimmunityChronic Viral InfectionHivMedicinePhase 1Virologic Impact
| Year | Citations | |
|---|---|---|
Page 1
Page 1